{
    "clinical_study": {
        "@rank": "122857", 
        "acronym": "UPGRADE", 
        "brief_summary": {
            "textblock": "UPGRADE aims to see whether data from Pharmacogenomic Testing (PGx) can help physicians\n      manage patient medication regimens and assess if the testing has an effect on reducing\n      adverse drug reactions, hospitalizations and emergency department visits.\n\n      The way an individual processes a drug is in part determined by their genes, and  there is\n      known to be genetic variation between humans in the way drugs are metabolized.  The study of\n      the way genes affect a person's response to drugs is known as \"Pharmacogenomics.\""
        }, 
        "brief_title": "Utility of PharmacoGenomics for Reducing Adverse Drug Effects", 
        "completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Genetics of Drug Metabolism", 
        "condition_browse": {
            "mesh_term": "Drug Toxicity"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject underwent pharmacogenomic testing for genes known to influence metabolism of\n             at least one target drug with the prior 1-year period\n\n          -  Subject is able and willing to provide written informed consent\n\n          -  Subject has a history of at least one target drug related adverse event or an\n             inadequate therapeutic effect from target drug over the 12-month period preceding\n             receipt of pharmacogenomic test results\n\n        Exclusion Criteria:\n\n          -  Subject is currently hospitalized\n\n          -  Subject's medical and medication history is unavailable over the 90-day periods\n             preceding and following the receipt of pharmacogenomic test results\n\n          -  Subject is unable to provide an accurate history due to mental incapacity\n\n          -  Subject is known to have undergone prior pharmacogenomic testing for genes specific\n             to the target drugs within the 2-year period preceding enrollment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Male and female subjects over the age of 18, receiving at least one medication with\n        metabolism known to depend on genetic allelic variation."
            }
        }, 
        "firstreceived_date": "March 4, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081872", 
            "org_study_id": "2013-101"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pharmacogenomics", 
            "Target Drug Related Adverse Events (TDAE)"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Michael Samuel, MD", 
                    "phone": "626-574-0188"
                }, 
                "facility": {
                    "address": {
                        "city": "Arcadia", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91007"
                    }, 
                    "name": "Retina Institute of California"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Gina Vendetti, MD", 
                    "phone": "561-447-0614"
                }, 
                "facility": {
                    "address": {
                        "city": "Boca Raton", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33432"
                    }, 
                    "name": "Boca Raton Clinical Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Seep, MD", 
                    "phone": "337-292-0885"
                }, 
                "facility": {
                    "address": {
                        "city": "Lake Charles", 
                        "country": "United States", 
                        "state": "Louisiana", 
                        "zip": "70601"
                    }, 
                    "name": "Centex Studies Inc"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Walter Duffy, MD", 
                    "phone": "402-817-2235"
                }, 
                "facility": {
                    "address": {
                        "city": "Lincoln", 
                        "country": "United States", 
                        "state": "Nebraska", 
                        "zip": "68526"
                    }, 
                    "name": "Premier Psychiatric Research Institute, LLC"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Marc S Whitman, MD", 
                    "phone": "609-815-7773"
                }, 
                "facility": {
                    "address": {
                        "city": "Trenton", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08638"
                    }, 
                    "name": "Pennington Infectious Disease Associates"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michael Rotman, MD", 
                    "phone": "512-328-4253"
                }, 
                "facility": {
                    "address": {
                        "city": "Austin", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78735"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Letreise Winkfield, MD", 
                    "phone": "956-682-0091"
                }, 
                "facility": {
                    "address": {
                        "city": "Edinburg", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78539"
                    }, 
                    "name": "Letriese Winkfield MD PA"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jacob Locke, MD", 
                    "phone": "937-689-5169"
                }, 
                "facility": {
                    "address": {
                        "city": "Harlingen", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78550"
                    }, 
                    "name": "2224 S 77 Sunshine Strip Ste 96, Box #193"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Hiram Garcia, MD", 
                    "phone": "956-342-2626"
                }, 
                "facility": {
                    "address": {
                        "city": "Pharr", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78577"
                    }, 
                    "name": "Centex Studies Inc"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Utility of PharmacoGenomics for Reducing Adverse Drug Effects", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint of the study is the binary occurrence of meaningful change in drug regimen, defined for each subject as:\nA genotype known to affect a target drug is identified by PGx testing, AND\nThe treating physician makes at least one target drug regimen change in dose, frequency, or route of administration, or when target drug discontinuation or substitutions occur.", 
            "measure": "Occurrence of Meaningful Change in Drug Regimen", 
            "safety_issue": "No", 
            "time_frame": "90 Days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081872"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Changes in target drug regimen over the 90-day period preceding receipt of PGx results, compared to the changes made in the 90-day period thereafter", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "measure": "Number of Target Drug-Related Adverse events (TDAE) over the 90-day period preceding receipt of PGx test results compared with the number over the 90-day period after the test", 
                "safety_issue": "No", 
                "time_frame": "90 days"
            }, 
            {
                "measure": "Target-drug related outpatient clinic visits, emergency department visits, and hospitalizations over the 90-day period prior to the receipt of PGx test results, compared to the number of visits over the 90-day period following testing.", 
                "safety_issue": "No", 
                "time_frame": "90 Days"
            }
        ], 
        "source": "Companion Dx Reference Lab, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Companion Dx Reference Lab, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "90 Days", 
        "verification_date": "May 2014"
    }
}